Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Liao

Showing results (581-590 of 588) with videos related to

Pageof 59
Sort By:
You have reached the last page of results.This site can display upto 588 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 18, 2025
Reprogramming Lung Redox Homeostasis by NIR Driven Ultra-Small Pd Loaded Covalent Organic Framework Inhibits NF-κB Pathway for Acute Lung Injury ImmunotherapyDoudou Lei, Lin Liao, Tao Qin, et al.
Mediators of Inflammation|February 26, 2026
The Role of APOL1 in Necrotizing Enterocolitis and Its Promise as a Diagnostic BiomarkerJie-Ting Lu, Qiu-Hua Wang, Ying-Yan Liu, et al.
Biomedicine|June 15, 2017
Autophagy and its link to type II diabetes mellitusJai-Sing Yang, Chi-Cheng Lu, Sheng-Chu Kuo, et al.
Lancet (London, England)|November 26, 2008
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trialEdward S Kim, Vera Hirsh, Tony Mok, et al.
The Lancet. Oncology|May 2, 2016
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trialJohan F Vansteenkiste, Byoung Chul Cho, Tonu Vanakesa, et al.
Nature Medicine|May 13, 2022
Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trialDalong Zhu, Xiaoying Li, Jianhua Ma, et al.
Translational Lung Cancer Research|July 28, 2018
A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panelYi-Long Wu, Chang-Li Wang, Mei-Lin Liao, et al.
ESMO Open|August 30, 2017
A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panelYi-Long Wu, Chang-Li Wang, Yan Sun, et al.
Pageof 59

Showing results (581-590 of 588) with videos related to

Sort By:
Pageof 59
You have reached the last page of results.This site can display upto 588 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 18, 2025
Reprogramming Lung Redox Homeostasis by NIR Driven Ultra-Small Pd Loaded Covalent Organic Framework Inhibits NF-κB Pathway for Acute Lung Injury ImmunotherapyDoudou Lei, Lin Liao, Tao Qin, et al.
Mediators of Inflammation|February 26, 2026
The Role of APOL1 in Necrotizing Enterocolitis and Its Promise as a Diagnostic BiomarkerJie-Ting Lu, Qiu-Hua Wang, Ying-Yan Liu, et al.
Biomedicine|June 15, 2017
Autophagy and its link to type II diabetes mellitusJai-Sing Yang, Chi-Cheng Lu, Sheng-Chu Kuo, et al.
Lancet (London, England)|November 26, 2008
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trialEdward S Kim, Vera Hirsh, Tony Mok, et al.
The Lancet. Oncology|May 2, 2016
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trialJohan F Vansteenkiste, Byoung Chul Cho, Tonu Vanakesa, et al.
Nature Medicine|May 13, 2022
Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trialDalong Zhu, Xiaoying Li, Jianhua Ma, et al.
Translational Lung Cancer Research|July 28, 2018
A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panelYi-Long Wu, Chang-Li Wang, Mei-Lin Liao, et al.
ESMO Open|August 30, 2017
A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panelYi-Long Wu, Chang-Li Wang, Yan Sun, et al.
Pageof 59